| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |